- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Noncompliance in AIDS Research
Hastings Center Report 20 (5):24-32 (1990)
Abstract
Participants in AIDS research may justify noncompliance with protocols by a “coercion defense.” While this defense may not be philosophically successful, a prudent social policy can enhance compliance by encouraging community participation and providing greater access to non‐validated therapies.Other Versions
No versions found
My notes
Similar books and articles
Nonvalidated Therapies and HIV Disease.Benjamin Freedman - 1989 - Hastings Center Report 19 (3):14-20.
AIDS: Public Policy and Biomedical Research.Sandra Panem - 1985 - Hastings Center Report 15 (4):23-26.
Ohrp Compliance Oversight Letters: An Update.Carol Weil - 2010 - IRB: Ethics & Human Research 32 (2):1-6.
Clinical Care and Research in AIDS.Paul Volberding & Donald Abrams - 1985 - Hastings Center Report 15 (4):16-18.
AIDS: Ethics and Public Policy.Daniel M. Fox, Douglas A. Feldman, Thomas M. Johnson, Christine Pierce & Donald VanDeVeer - 1988 - Hastings Center Report 18 (4):42.
Tipping point, over the top, or just noncompliance as usual?Greg Koski - 2008 - Hastings Center Report 38 (2):27-29.
Facilitating Ukrainian Refugees’ Continued Participation in Clinical Trials.Agata Bloswick, David Mustra, Oksana Harasymiv & Alex Dubov - 2022 - Hastings Center Report 52 (3):6-8.
Ethical standards, attitudes toward risk, and intentional noncompliance: An experimental investigation. [REVIEW]Dipankar Ghosh & Terry L. Crain - 1995 - Journal of Business Ethics 14 (5):353 - 365.
Analytics
Added to PP
2013-11-22
Downloads
21 (#1,049,356)
6 months
1 (#1,572,794)
2013-11-22
Downloads
21 (#1,049,356)
6 months
1 (#1,572,794)
Historical graph of downloads
Citations of this work
Subversive Subjects: Rule-Breaking and Deception in Clinical Trials.Rebecca Dresser - 2013 - Journal of Law, Medicine and Ethics 41 (4):829-840.
For-Profit Clinical Trials in Developing Countries—Those Troublesome Patient Benefits.Udo Schuklenk - 2010 - American Journal of Bioethics 10 (6):52-54.
The Moral Case for Granting Catastrophically Ill Patients the Right to Access Unregistered Medical Interventions.Udo Schuklenk & Ricardo Smalling - 2017 - Journal of Law, Medicine and Ethics 45 (3):382-391.
And there we go again: the ethics of placebo-controlled RCT in case of catastrophic illness.Udo Schuklenk - 2015 - Journal of Medical Ethics 41 (12):952-953.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-99fc7d78b-qtxsx uwo